- AVF Academy
- Foam Sclerotherapy
Foam Sclerotherapy
Foam Sclerotherapy
- Sep 18, 2026This final AVF Pelvic Venous Disorders Summit session addressed zone two and three extra-pelvic varices. A case-based talk em... more details
- Sep 14, 2026This Fellows Course industry talk reviewed Varithena, a 1 percent polidocanol injectable microfoam approved for incompetent g... more details
- Sep 14, 2026This Fellows Course discussion covered sclerotherapy agent choice, with most faculty preferring polidocanol for telangiectasi... more details
- Jul 16, 2026This issue focuses on aesthetic venous care, opening with a histology-based framework for matching sclerotherapy or laser tre... more details
- Mar 1, 2026Two talks on bringing an advanced practice provider into a vein practice and on the judgment behind good cosmetic sclerothera... more details
- Mar 1, 2026The opening scientific session paired registry analyses with randomized data and a consensus exercise. Presenters reported th... more details
- Nov 12, 2025This joint EAVLA and AVF phlebology webinar reviewed four JVS Venous and Lymphatic studies. A 346 patient cohort found foam s... more details
- Feb 19, 2025An international panel covers a prosthetic venous valve's pivotal trial results and speculative future materials, alongside a... more details
- Feb 18, 2025This Monday session opened with a study linking venous leg ulcers to higher all cause mortality in patients with chronic veno... more details
- Feb 18, 2025This international session honoring Doctor Lionel Villavicencio opened with a randomized trial showing ultrasound guided foam... more details
- Feb 17, 2025An APP session on pelvic venous disorders introduces the SVP classification system for symptoms, vein, and pathophysiology, t... more details
- Feb 17, 2025A hands-on sclerotherapy workshop reviews the FDA-approved sclerosing agents polidocanol and sodium tetradecyl sulfate, their... more details
- Jan 30, 2025This innovation-themed issue features new venous technologies presented by industry partners and clinicians. Cardiologist Ari... more details
- Jan 18, 2025This joint AVF and EVLA phlebology webinar reviewed three JVS Venous and Lymphatic papers plus an industry update. A German r... more details
- Jul 25, 2024This Vein Specialist issue explores why physicians choose one sclerosing agent over another for treating telangiectasias and... more details
- Mar 5, 2024This session opened with a masterclass on ethanol sclerotherapy for venous and lymphatic malformations, showing durable ablat... more details
- Mar 5, 2024This session opened with a masterclass on a multidisciplinary approach to pelvic venous disorders, combining gynecologic eval... more details
- Mar 4, 2024This session opens questioning what is known about venous hemodynamics, showing reflux volume and saphenous diameter correlat... more details
- Mar 3, 2024This live demonstration session pairs real-time sclerotherapy injections on patients with running expert commentary on techni... more details
- Mar 3, 2024An entry-level sclerotherapy course for advanced practice providers covered the full workflow of treating spider and reticula... more details
- Sep 22, 2023This issue of Vein Specialist reviews three emerging technologies for superficial venous disease. Amsel's SCureClamp uses two... more details
- Feb 24, 2023This Allied Health and Aesthetics program opened with a blueprint for onboarding advanced practice providers into a vein prac... more details
- Feb 23, 2023This superficial venous session reviewed thermal and non-thermal ablation options and reinforced that history, physical exam,... more details
- Feb 26, 2022This aesthetic vein session opened with a case for building a cosmetic practice around trained staff and dedicated equipment,... more details

